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of both CFSC-2G and isolated HSC was inhibited dose-dependently by
EMD409915, with complete abrogation of migration at 10-6M. There was
no effect of beta 3 integrin inhibition on cell proliferation in both cell lines.
Pre-incubation of the cells with the beta 3 integrin inhibitor completely
blocked PDGF-stimulated phosphorylation of p38 MAPK and FAK.
Conclusion: PDGF-BB-induced HSC migration can be completely
blocked in vitro by the beta 3-integrin specific non-peptidic inhibitor
EMD409915. Specific integrin inhibition provides a novel promising strat-
egy for antifibrotic therapy.
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Activated human HSC express the chemokine receptor CXCR3, which
binds IP-10 and induces cell migration. Recently, an alternatively spliced
isoform, CXCR3b, has been described in microvascular endothelial cells.
Unlike the “classic” isoform, CXCR3a, CXCR3b leads to growth inhibition
and apoptosis, and mediates angiostatic effects of IP-10. In HSC, the pos-
sible role of CXCR3b expression is unknown. In this study we investigated
the biologic significance of the IP-10/CXCR3 system in HSC, consider-
ing the role of CXCR3b. Apoptosis of activated HSC was induced by Fas
activation and/or protein synthesis inhibition by cycloheximide, and was
evaluated with PARP cleavage (western blotting) and caspase 3 activation
(fluorometric assay). IP-10 secretion by HSC was measured by ELISA.
IP-10 was detectable in HSC supernatants, and increased in response to
IFN-gamma. Activating anti-Fas antibody and/or cycloheximide induced
HSC apoptosis, which was inhibited by low concentrations (20ng/ml) of
IP-10. However, the inhibition of apoptosis by IP-10 was variable in dif-
ferent cell lines and tended to disappear after prolonged cell culture, when
a pro-apoptotic effect was actually observed. To test for this apparent para-
dox, expression of CXCR3a and CXCR3b was evaluated in cells that did
not show increased survival with IP-10. Surprisingly, these cells expressed
much higher levels of CXCR3b than CXCR3a, thus providing a mecha-
nism for the reversal of the anti-apoptotic effects by IP-10. We conclude
that HSC may express both CXCR3 isoforms, that mediate opposing ef-
fects of IP-10 on apoptosis. The ultimate biologic effect of autocrine IP-10
secretion depends on the relative expression of the two isoforms.
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Background and aim: Tissue homeostasis and turnover are guaranted by
the stem proliferating reserve. Several studies, performed with immunode-
ficient animals, suggested that a particular degree of plasticity is shown by
the haematopoietic stem cell (HSC) compartment, that could be a source
for liver regeneration. We aimed to explore the hepatic differentiation po-
tential of human HSC also in immunocompetent rats after a toxic liver
damage.
Materials and methods: Winstar rats were so sorted: Group A: liver dam-
age with Allyl Alcohol (AA) intraperitoneally (ip) injection and killing at
2, 4, 7 days after. Group B: human HSC injection (ip) and killing at 1,
3, 6 days after. Group C: liver damage (AA, ip); human HSC injection
(ip) after 1 day and killing at 1, 3, 6 days after HSC injection. Group D:
sacrifice without any treatment. Livers, spleens and bone marrows were
analysed for human HSC detection using Flow Cytometry (FCM); livers
were also tested with immunohistochemistry (IHC) to demonstrate HSC
transdifferentiation into hepatocytes.
Results: FCM confirmed the presence of human HSC (groups B and C)
and revealed their selective recruitment into the damaged livers (group C)
in comparison with the controls (group B). IHC demonstrated the HSC
capability to transdifferentiate into hepatic cells.
Conclusions: Our study demonstrated that HSC are able to contribute in
liver regeneration after an acute toxic damage in not-myeloablated recipi-
ents, opening doors to speculations about their future applications for hu-
man liver diseases, without the need of immunosuppressive pre-treatments.
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Background: The semisynthetic plant alkaloid Halofuginone (HAL) was
reported to ameliorate rat liver fibrosis. We recently found that the antifi-
brotic potential of HAL is likely to be associated with a strong MMP in-
duction in activated hepatic stellate cells (HSCs). Our present study aimed
to investigate molecular mechanisms involved in this effect.
Methods: The HSC line CFSC-2G and isolated rat HSCs were incubated
with increasing concentrations of HAL. mRNA steady state levels of MMP-
3, -13 were quantified by real-time PCR. Interstitial collagenase activities
were assessed in conditioned media. p38 MAPK and nuclear factor kappa
B (NF kappa B) pathways were evaluated by western blotting (WB) of
cell lysates and nuclear extracts with phospho-p38 and p65 NF kappa B
antibodies, respectively. SB 203580 and MG132 were used to block p38
and NF kappa B signaling.
Results: Interstitial collagenase activity of HSC cultures increased dose-
and time-dependently up to 3-fold in the presence of HAL at 20-200 nM.
At 200 nM HAL rapidly up-regulated MMP-3 and MMP-13 (interstitial
collagenase) mRNA expression 10-50-fold in CFSC-2G and HSC, which
was dose-dependently inhibited by pre-incubation of cells with both SB
203580 and MG132 prior to treatment with HAL. Activation of p38 and
NF kappa B pathways was confirmed by WB in HSC treated with HAL for
0,5-6 hours.
Conclusions: 1. HAL stimulates interstitial collagenolytic activity of HSC
in a hitherto unmatched way via activation of p38 MAPK and NF kappa B
pathways; 2. HAL is a highly promising drug for combination therapy of
liver fibrosis.
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Background: Expression of tissue inhibitor of metalloproteinases-1
(TIMP-1) is closely correlated with liver fibrogenesis. In the context of
TIMP-1-antagonisation by matrix metalloproteinases (MMPs) we inves-
